Lupin Ltd.: Another Undervalued Generic Drugs Powerhouse
The common stock could be worth Rs. 1874 at 25x FY2018 consensus EPS estimate (33% potential upside). Using both forward EV/EBITDA and forward P/E...
498 Views
SillaJen IPO Part 2 - Growth Potential & Appropriate Valuation Level
* In Part 2 (as below), I summarized the growth potential and appropriate valuation level of SillaJen.Apparently, not many people are doubtful...
406 Views
Monsanto/Bayer Merger to Face Opposition in Africa
Bayerâs $66 billion bid for genetically modified seed and herbicide producer Monsanto faces strong opposition from a range of stakeholders in South...
236 Views
Monsanto Progresses Soybean Business in Brazil
Monsanto is likely to profit from Brazilâs economic crisis, as the country â the worldâs largest soybean exporter â strives to boost production and...
266 Views
Bayer Keeps Close Watch on EU Deliberations on Monsanto's Roundup
As Bayer AG contemplates a higher offer for Monsanto it will be keeping close tabs on the European Unionâs ongoing debate about renewing the...
326 Views